Upgrade to SI Premium - Free Trial

TG Therapeutics (TGTX)

53.20 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/9/26)

Latest Headlines

TG Therapeutics Highlights New Clinical Data Across Multiple Sclerosis Portfolio at MSToronto2026 October 21, 2026 8:52 AM - BizWire TG Therapeutics publishes five-year Briumvi comparison study October 12, 2026 7:30 AM - StreetInsider TG Therapeutics Announces Publication of Five-Year Comparative Analysis of BRIUMVI Versus Ocrelizumab and Ofatumumab in Relapsing Multiple Sclerosis October 12, 2026 7:30 AM - BizWire TG Therapeutics Announces Schedule of Data Presentations at MSToronto2026 October 8, 2026 7:30 AM - BizWire Form 4 TG THERAPEUTICS, INC. For: Sep 10 Filed by: Charney Laurence N September 14, 2026 5:01 PM - SEC Filing Form 144 TG THERAPEUTICS, INC. Filed by: Charney Laurence N September 10, 2026 4:46 PM - SEC Filing Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market September 10, 2026 8:30 AM - StreetInsider TG Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference September 10, 2026 7:30 AM - Globe NewsWire Form 4 TG THERAPEUTICS, INC. For: Aug 06 Filed by: Charney Laurence N August 7, 2026 5:01 PM - SEC Filing TG Therapeutics (TGTX) PT Raised to $72 at JPMorgan August 7, 2026 9:40 AM - StreetInsider Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update August 6, 2026 7:01 AM - BizWire Form 10-Q TG THERAPEUTICS, INC. For: Jun 30 August 5, 2026 5:02 PM - SEC Filing TG Therapeutics (TGTX) PT Raised to $78 at H.C. Wainwright August 4, 2026 6:50 AM - StreetInsider Form 8-K TG THERAPEUTICS, INC. For: Aug 03 August 3, 2026 7:06 AM - SEC Filing TG Therapeutics raises 2026 revenue guidance on Briumvi sales growth August 3, 2026 7:03 AM - StreetInsider TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance August 3, 2026 7:00 AM - Globe NewsWire Buy this biotech stock into Q2 earnings: Analyst August 1, 2026 4:00 AM - StreetInsider TG Therapeutics to Host Conference Call on Second Quarter 2026 Financial Results and Business Update July 29, 2026 7:30 AM - Globe NewsWire TG Therapeutics (TGTX) PT Raised to $86 at B.Riley July 27, 2026 8:47 AM - StreetInsider Full Article List